drugset / Trial / NCT03541564

An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects

NCT03541564

Phase 1 Completed 84 enrolled Bristol-Myers Squibb
RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a study to investigate the experimental medication BMS-986165 in healthy participants in order to study the effects it has on electrocardiogram results.

Timeline

Start
2018-05-30
Primary completion
2018-09-04
Completion
2018-09-04

Drugs

EvaluationDrugModalityDoseRoute
Subject CRAVACITINIB Small molecule Oral
Comparator Moxifloxacin Small molecule Oral